A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is ฿6,065.64, with a 24-hour trading volume of ฿132.31M. The asset's market cap is ฿9.4T, after moving -0.93% in the last day.
Tokenized AstraZeneca PLC is trading at ฿3,474.58, with a tokenized market cap of ฿475.96M and a 24-hour trading volume of ฿23.16M. The tokenized asset has moved 0.67% in the past 24 hours.